2) H.pylori antibody
幽门螺杆菌抗体
1.
Clinical significance of co-determination of serum CEA, CA19-9 and H.pylori antibody in patients with gastric carcinoma;
胃癌患者血清CEA、CA19-9与幽门螺杆菌抗体联检的临床意义
3) anti-Helicobacter pylori
抗幽门螺杆菌
1.
Progress of researching the anti-Helicobacter pylori bioactivity substances;
抗幽门螺杆菌生物活性物质的研究进展
4) Helicobacter pylori Antibody
抗幽门螺杆菌抗体
1.
Results:positive rate Helicobacter pylori antibody hasn t significant differencebetween coronary heart disease group with digestive system disease group(P>0.
方法:冠心病组175例,消化系疾病组150例,健康对照组120例,均抽静脉血取血清一滴测定血清抗幽门螺杆菌抗体 IgG。
5) IgG against H. pylori
抗幽门螺杆菌-IgG抗体
6) Helicobacter pylori
幽门螺杆菌
1.
Fermentable Study on the Gene Engineering E.coli of Helicobacter pylori Urease B;
幽门螺杆菌尿素酶B亚单位基因工程菌发酵工艺的研究
2.
The relationship between the Helicobacter pylori infection and Fas,Fas-L expression in precancerous lesions;
胃癌前病变中Fas、Fas-L表达及与幽门螺杆菌感染的关系
3.
The resistance of Helicobacter pylori to clarithromycin in Huainan area and its molecular mechanism for drug-resistance;
淮南地区幽门螺杆菌对克拉霉素耐药性及其耐药分子机制的研究
补充资料：抗代谢类抗肿瘤药物
抗代谢类抗肿瘤药物
antimetabolite agents
此类抗癌药对核酸代谢物与酶结合反应有相互竞争作用，影响与阻断了核酸的合成，如氟尿嘧啶、甲氨蝶呤、呋喃氟尿嘧啶、阿糖胞苷等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条